ARCHIVES

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

This article is from The Cancer Letter archive.

Vol. 22 No. 35 | September 13, 1996

Download PDF Visit The Full Archive

Related Articles

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

In Brief: House Passes Bill Extending Saccharin Status To 1981; Execs No Enthusiastic Over New SES

August 3, 1979

In Brief: ACCC Honors Henry Lynch; Gunderson Names Chair, Mayo Oncology Department

October 11, 1996

In Brief: Bailes Succeeds Lichor As ASCO President; Einhorn Is President-Elect; Durant Honored

May 21, 1999

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010